{
    "organizations": [],
    "uuid": "776257b8b3ee5dc45d02aff49170f51870799537",
    "author": "",
    "url": "https://www.reuters.com/article/brief-fennec-pharmaceuticals-receives-fa/brief-fennec-pharmaceuticals-receives-fast-track-designation-by-fda-for-pedmark-idUSASC09T46",
    "ord_in_thread": 0,
    "title": "BRIEF-Fennec Pharmaceuticals Receives Fast Track Designation By FDA For Pedmark",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 21, 2018 / 11:01 AM / in 15 minutes BRIEF-Fennec Pharmaceuticals Receives Fast Track Designation By FDA For Pedmark Reuters Staff March 21 (Reuters) - Fennec Pharmaceuticals Inc: * FENNEC PHARMACEUTICALS RECEIVES FAST TRACK DESIGNATION BY FDA FOR PEDMARK * FENNEC PHARMACEUTICALS- U.S. FDA GRANTED PEDMARK FAST TRACK DESIGNATION FOR PREVENTION OF CISPLATIN-RELATED OTOTOXICITY IN PEDIATRIC PATIENTS WITH SR-HB Source text for Eikon: Further company coverage:",
    "published": "2018-03-21T12:59:00.000+02:00",
    "crawled": "2018-03-21T13:21:51.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "minute",
        "pharmaceutical",
        "receives",
        "fast",
        "track",
        "designation",
        "fda",
        "pedmark",
        "reuters",
        "staff",
        "march",
        "reuters",
        "fennec",
        "pharmaceutical",
        "inc",
        "fennec",
        "pharmaceutical",
        "receives",
        "fast",
        "track",
        "designation",
        "fda",
        "pedmark",
        "fennec",
        "fda",
        "granted",
        "pedmark",
        "fast",
        "track",
        "designation",
        "prevention",
        "ototoxicity",
        "pediatric",
        "patient",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}